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Abstract
Consumption of trans fats is associated with an increase of cardiovascular disease (CVD) risk. To
comply with regulatory policies and public health authorities recommendations, trans fats should
be replaced in food products. The study by Sundram et al. (Nutrition & Metabolism 2007, 4:3)
reporting the effect on CVD risk factors of interesterified fat (IE) and partially hydrogenated
soybean oil (PHSO) compared to palm olein (POL) has been critically analyzed. The study design
and in particular the composition of the tested fats was not suitable to properly answer the
question raised regarding the effect of alternative ingredients to trans fats on plasma lipids. The
observed effects are divergent with predicted data derived from the literature model consolidated
using the individual results of 60 randomized clinical trials. The results of the study published by
Sundram and co-workers have to be considered with awareness.
Dear Editor,
Diet and health is now recognized to be a critical factor in
causing diseases of metabolic origin. Fats in particular are
documented to influence the risk of various degenerative
diseases. Consumption of monounsaturated trans  fatty
acids (TFA) has been shown to be associated with
increased risk of cardiovascular disease (CVD) [1,2]. Most
public health agencies have implemented labeling or
ingredient restrictions on trans fats. Alternative ingredi-
ents to trans fats are now available in the food supply
allowing the reformulation of food products that is man-
datory to comply with policies and advices from health
authorities. The physical properties and the chemical sta-
bility of trans  fats were the two major reasons that
explained the popularity of this ingredient. The reformu-
lation of food products is difficult because the intrinsic
characteristics of the products should be maintained.
Ingredients such as palm olein (POL) produced by physi-
cal fractionation of palm fat or interesterified (IE) fats pro-
duced from fully hydrogenated vegetable oils could be
used as alternative ingredients to trans fats in food prod-
ucts. The major saturated fatty acids present in these fats
are palmitic and stearic acids. These two fats are produced
using industrial processes flexible enough to obtain the
desire physical properties. In a recent paper published in
The Journal [3], Sundram and co-workers reported on the
effect on CVD risk factors of partially hydrogenated soy-
bean oil (PHSO), IE and POL. The main comparison was
IE and PHSO versus POL. The composition and the phys-
ical properties of the three fats compared were not the
same. The melting points of the IE and PHSO fats were
about 15 to 20°C higher that POL, leading to different
applications in the food industry. As a matter of fact, the
relative distribution between saturated, monounsaturated
and polyunsaturated fatty acids were different for all the
fats evaluated. In particular, the content of saturated fatty
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Predicted (open bars) and measured (grey bars) changes in HDL-C (A), total cholesterol (B), LDL-C (C), and total cholesterol  to HDL-C ratio (D) when consumption of partially hydrogenated soybean oil (PHSO) or interesterified (IE) fat is compared to  palm olein (POL) Figure 1
Predicted (open bars) and measured (grey bars) changes in HDL-C (A), total cholesterol (B), LDL-C (C), and total cholesterol 
to HDL-C ratio (D) when consumption of partially hydrogenated soybean oil (PHSO) or interesterified (IE) fat is compared to 
palm olein (POL). Measured data are adapted from the study of Sundram and co-workers (3). Estimation of predicted effects of 
the PHSO and IE compared to POL have been calculated using the equations proposed by Mensink and co-workers (2) and the 
fatty acid composition of the fats used in the study from Sundram and co-workers (3)
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acid was about 30% higher in the IE fat than in the POL
fats; and the content in monounsaturated fatty acids, 2.3
times lower in IE than in POL.
In the frame of the on-going efforts aiming at replacing
trans fats in food products, a pertinent strategy would have
been to compare, in a double blind fashion, the effects on
CVD risk of food items produced from three fats having
the same physical properties (i.e.  identical melting
points). The primary objective (the hypothesis) would
have been to compare the nutritional effects of POL and
IE to PHSO in order to identify the healthy alternative to
trans fat (PHSO) in a controlled design. The experimental
conditions used by the investigators were not suitable to
answer the question. Indeed, changes in CVD risk factors
such as low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C), total cho-
lesterol and diagnostic ratios were expected from litera-
ture data.
It is possible to predict the effects, on plasma lipids, of fats
and oils using mathematical models obtained recently, as
a result of a large metaanalysis conducted by Mensink and
co-workers [2]. The predicted and reported effects of the
fats evaluated in the study from Sundram and co-workers
[3] are given in the Figure 1. Confidence intervals (CI)
were constructed using metaanalysis coefficients confi-
dence intervals [2]. They represent an estimation of what
should be CI and they help defining the credibility of
some study results according to metaanalysis results. The
effect on HDL-C of IE and PHSO compared to POL meas-
ured in the clinical trial compared with the expected effect
predicted by the literature model (see Figure 1A). How-
ever, the effects on total cholesterol (see Figure 1B), on
LDL-C (see Figure 1C) and on the diagnostic ratio total
cholesterol to HDL-C (see Figure 1D) differ from the pre-
diction.
Sundram and co-workers [3] hypothesized that the unex-
pected effects of IE on the monitored CVD risk factors
could be due to the regiospecific distribution of stearic
acid on the triacylglycerols (TAG) formed by chemically-
catalyzed interesterification. The goal of the interesterifi-
cation process is to change the physical properties of the
starting material: a blend of fats and oils. The melting
point of the interesterified fat is usually lower. The analyt-
ical method used by Sundram and co-workers [3] to ana-
lyze the test fats is widely used to determine the TAG
profile of edible fats and oils. However, this method is not
suitable to assess the regiospecific distribution of fatty
acids or the molecular species of TAG. Two TAG regio-iso-
mers have the same fatty acids esterified in the Sn-glycerol
but not at the same position [e.g. 1,2-dipalmitoyl-3-ole-
oyl-glycerol (PPO), and 1,3-dipalmitoyl-2-oleoyl-glycerol
(POP)]. Reversed-phase high-performance liquid chro-
matography (RP-HPLC) analysis of TAG cannot discrimi-
nate TAG regioisomers. The difference between PPO and
POP is that the oleic acid is esterified in Sn-1(3) or Sn-2
position on the Sn-glycerol, respectively. These structural
data could be assessed by either partial deacylation of TAG
using pancreatic lipase or Grignard reagent [4], by mass-
spectrometry [5] or by NMR [6].
The neutral effect of stearic acid, compared to oleic acid,
on CVD risk factors such as HDL-C, LDL-C and diagnostic
ratio has been recently confirmed by Thijssen and Men-
sink [7]. These recent data are consistent with studies
showing that stearic acid compared to oleic acid does not
alter plasma lipids [8-10]. The results obtained by Sun-
dram and co-workers [3] are divergent with the predicted
data, derived from the literature model consolidated
using the results of 60 randomized clinical trials. The
design of the study was not suitable to challenge the
hypothesis raised by the investigators. Alternatives to
replace trans fats in food products are available. However,
the study published by Sundram and co-workers does not
allow concluding that palm oil is healthier than interest-
erified fats.
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